Riskpilot← Back to searchSign inGet full accessEE Medical AB
ABActiveOrg 5568385826Rödhakevägen 24General medical practice activities · NACE 8621Est. 20111 employees
Revenue 2025
SEK 1,9M
+13% vs 2024
EBITDA margin
33.3%
+43% vs 2024
Equity ratio
46.1%
Financial strength
Net profit 2025
SEK 471K
+9% vs 2024
| Revenue | SEK 1,9M | +13% |
| EBITDA | SEK 633K | +43% |
| Net profit | SEK 471K | +9% |
| Total assets | SEK 1,4M | +10% |
| Equity | SEK 650K | +12% |
| Employees | 1 | — |
Legal name
EE Medical AB
Org number
5568385826
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
17 januari 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva verksamhet med läkarpraktik'; forskning och utveckling av läkemedel och konsulterande verksamhet inom nämnda områden'; uthyrning av vårdpersonal'; friskvård'; utbildning' äga och förvalta fast och lös egendom'; bedriva handel med värde= papper'; samt annan därmed förenlig verksamhet.
Address
Rödhakevägen 24
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 585 | 1 586 | 1 721 | 1 681 | 1 902 |
| Staff expenses | — | −901 | −998 | −1 059 | −1 096 |
| EBITDA | 369 | 517 | 538 | 442 | 633 |
| Depreciation & amort. | −7 | −7 | −7 | −7 | — |
| EBIT | 362 | 511 | 532 | 435 | 633 |
| Net financials | — | −0 | 1 | 17 | 16 |
| Profit before tax | 269 | 382 | 470 | 549 | 599 |
| Tax | −59 | −81 | −101 | −119 | −128 |
| Net profit | 210 | 302 | 369 | 430 | 471 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 249 | 954 | 1 248 | 1 277 | 1 410 |
| Equity | 378 | 280 | 449 | 579 | 650 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 483 | 158 | 220 | 217 | 228 |
| Total debt | 483 | 158 | 220 | 217 | 228 |
EBITDA margin
33.3%
This company
15.8%
Market median
+111% vs market
20212025
Equity ratio
46.1%
This company
38.2%
Market median
+21% vs market
20212025
Return on equity
72.5%
This company
18.4%
Market median
+294% vs market
20212025
Net profit margin
24.8%
This company
8.1%
Market median
+206% vs market
20212025
Asset turnover
1.35×
This company
1.12×
Market median
+21% vs market
20212025
Debt / equity
1.17×
This company
0.62×
Market median
-89% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EE Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inger Kristina Louise Eneroth | Audit | 0 companies |
| Caritha Iréne Margaretha Klasson | Deputy Board Member | 0 companies |
| Lars Fredrik Klasson | Board of Directors | 0 companies |